Advertisement
Screener

TECTONIC THERAPEUTIC, INC. (TECX) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

TECTONIC THERAPEUTIC, INC. Increase (Decrease) in Prepaid Expense and Other Assets

TECTONIC THERAPEUTIC, INC. (TECX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.18 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.13M, a 1515.71% increase year-over-year.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $46.00K.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$1.25M, a 158.94% decline year-over-year.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $753.00K, a 9.06% decline year-over-year.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$2.64M, a 182.78% decline from fiscal 2024.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $3.19M, a 213.44% increase from fiscal 2023.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.02M.
  • TECTONIC THERAPEUTIC, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$2.47M, a 222.20% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$1.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$1.18M
10-Q · filed 2026-08-06
-$69.00K
derived: sum of 3 quarters · filed 2026-08-06
$684.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$46.00K
10-Q · filed 2026-05-07
-$1.20M
derived: sum of 2 quarters · filed 2026-05-07
-$447.00K
derived: sum of 3 quarters · filed 2026-05-07
-$377.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$1.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$493.00K
derived: sum of 2 quarters · filed 2026-02-26
-$423.00K
derived: sum of 3 quarters · filed 2026-08-06
-$2.64M
10-K · filed 2026-02-26
2025-09-30$753.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$823.00K
derived: sum of 2 quarters · filed 2026-08-06
-$1.40M
10-Q · filed 2025-11-06
$716.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$70.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$2.15M
10-Q · filed 2026-08-06
-$37.00K
derived: sum of 3 quarters · filed 2026-08-06
$791.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$2.22M
10-Q · filed 2026-05-07
-$107.00K
derived: sum of 2 quarters · filed 2026-05-07
$721.00K
derived: sum of 3 quarters · filed 2026-05-07
$1.26M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$2.94M
derived: sum of 2 quarters · filed 2026-02-26
$3.48M
derived: sum of 3 quarters · filed 2026-02-26
$3.19M
10-K · filed 2026-02-26
2024-09-30$828.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$1.37M
derived: sum of 2 quarters · filed 2025-11-06
$1.08M
10-Q · filed 2025-11-06
$2.19M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$541.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$252.00K
10-Q · filed 2025-08-07
$1.36M
derived: sum of 3 quarters · filed 2025-08-07
$792.00K
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$289.00K
10-Q · filed 2025-05-08
-$884.00K
10-Q · filed 2024-05-09
$821.00K
derived: sum of 2 quarters · filed 2025-05-08
$251.00K
derived: sum of 3 quarters · filed 2025-05-08
$2.92M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$540.00K
derived: sum of 2 quarters · filed 2025-03-20
$3.21M
derived: sum of 3 quarters · filed 2025-03-20
$1.02M
10-K · filed 2025-03-20
-$5.15M
10-K · filed 2024-03-14
2023-09-30-$570.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$2.10M
derived: sum of 2 quarters · filed 2024-11-12
-$91.00K
10-Q · filed 2024-11-12
-$4.25M
10-Q · filed 2023-11-09
-$2.75M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$2.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$479.00K
10-Q · filed 2024-08-14
-$3.24M
10-Q · filed 2023-08-10
-$2.18M
derived: sum of 3 quarters · filed 2024-08-14
-$2.08M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$2.19M
10-Q · filed 2024-05-09
-$4.85M
derived: sum of 2 quarters · filed 2024-05-09
-$4.75M
derived: sum of 3 quarters · filed 2024-05-09
-$4.33M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$2.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$2.56M
derived: sum of 2 quarters · filed 2024-03-14
-$2.15M
derived: sum of 3 quarters · filed 2024-03-14
-$2.47M
10-K · filed 2024-03-14
2022-09-30$101.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$515.00K
derived: sum of 2 quarters · filed 2023-11-09
$195.00K
10-Q · filed 2023-11-09
-$516.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$414.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$94.00K
10-Q · filed 2023-08-10
-$617.00K
derived: sum of 3 quarters · filed 2023-08-10
$2.59M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$320.00K
10-Q · filed 2023-05-11
-$1.03M
derived: sum of 2 quarters · filed 2023-05-11
$2.18M
derived: sum of 3 quarters · filed 2023-05-11
$221.00K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$711.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23
$2.50M
derived: sum of 2 quarters · filed 2023-03-23
$541.00K
derived: sum of 3 quarters · filed 2023-03-23
$2.02M
10-K · filed 2023-03-23
2021-09-30$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$1.25M
derived: sum of 2 quarters · filed 2022-11-08
$2.73M
10-Q · filed 2022-11-08
$849.00K
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30-$1.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$478.00K
10-Q · filed 2022-08-09
-$2.36M
derived: sum of 3 quarters · filed 2022-08-09
$411.00K
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.48M
10-Q · filed 2022-05-10
-$403.00K
derived: sum of 2 quarters · filed 2022-05-10
$2.37M
derived: sum of 3 quarters · filed 2022-05-10
$1.35M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31-$1.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
$889.00K
derived: sum of 2 quarters · filed 2022-03-17
-$122.00K
derived: sum of 3 quarters · filed 2022-03-17
-$1.10M
10-K · filed 2022-03-17
2020-09-30$2.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$1.76M
derived: sum of 2 quarters · filed 2021-11-04
$782.00K
10-Q · filed 2021-11-04
$2.05M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
-$1.99M
10-Q · filed 2021-08-05
-$715.00K
derived: sum of 3 quarters · filed 2021-08-05
-$1.22M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$976.00K
10-Q · filed 2021-05-13
$296.00K
derived: sum of 2 quarters · filed 2021-05-13
-$209.00K
derived: sum of 3 quarters · filed 2021-05-13
$2.43M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18
$767.00K
derived: sum of 2 quarters · filed 2021-03-18
$3.40M
derived: sum of 3 quarters · filed 2021-03-18
$4.89M
10-K · filed 2021-03-18
2019-09-30-$505.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.13M
derived: sum of 2 quarters · filed 2020-11-05
$3.62M
10-Q · filed 2020-11-05
$5.51M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30$2.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$4.12M
10-Q · filed 2020-08-06
$6.02M
derived: sum of 3 quarters · filed 2020-08-06
$6.39M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.49M
10-Q · filed 2020-05-07
$3.38M
derived: sum of 2 quarters · filed 2020-05-07
$3.75M
derived: sum of 3 quarters · filed 2020-05-07
$4.33M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$1.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$2.27M
derived: sum of 2 quarters · filed 2020-03-16
$2.85M
derived: sum of 3 quarters · filed 2020-03-16
$3.04M
10-K · filed 2020-03-16
2018-09-30$370.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$949.00K
derived: sum of 2 quarters · filed 2019-11-07
$1.14M
10-Q · filed 2019-11-07
$1.40M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$579.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$768.00K
10-Q · filed 2019-08-08
$1.03M
derived: sum of 3 quarters · filed 2019-08-08
$918.00K
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$189.00K
10-Q · filed 2019-05-13
$449.00K
derived: sum of 2 quarters · filed 2019-05-13
$339.00K
derived: sum of 3 quarters · filed 2019-05-13
2017-12-31$260.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$150.00K
derived: sum of 2 quarters · filed 2019-03-25
$326.00K
10-K · filed 2019-03-25
2017-09-30-$110.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$66.00K
10-Q · filed 2018-11-13
2017-06-30$176.00K
10-Q · filed 2018-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Entera Bio Ltd. (ENTX)$0.485B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41